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Abstract
Background & Aims—Metabolic syndrome (MetS), characterized by abdominal obesity,
atherogenic dyslipidemia, elevated blood pressure, and insulin resistance is a major public health
concern in the United States. Omega-3 fatty acids have been relatively well studied in relation to
many individual cardiovascular risk factors; however, their effects on MetS are not well
established.
Methods—We conducted a cross-sectional study consisting of 4,941 participants from the
National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study to assess the relation of
dietary omega-3 fatty acids with the prevalence of MetS. Omega-3 intake was assessed using a
food frequency questionnaire and we used generalized estimating equations to estimate adjusted
odds ratios for prevalent MetS.
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Results—Our study population had a mean age (SD) of 52.1 (13.9) years and 45.9% were men.
The mean (SD) of dietary omega-3 fatty acids was 0.25g/day (0.27). From the lowest to the
highest quintile of dietary omega-3 fatty acids, multivariable adjusted ORs (95% CI) for MetS
were 1.00 (ref), 0.90 (0.72–1.13), 1.03 (0.82–1.28), 0.94 (0.74–1.18), and 0.99 (0.77–1.25),
respectively. In a secondary analysis, neither fish consumption nor dietary alpha-linolenic acid
was associated with MetS.
Conclusions—Our findings do not support an association between dietary omega-3 fatty acids
and MetS in a large US population.
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Introduction
Metabolic syndrome (MetS) has been a major public health concern in the United States for
the past few decades and its prevalence has been increasing due to rising rates of obesity.
The third National Health and Nutrition Examination Survey (NHANES) showed that
approximately one-fourth of the United States’ adult population has MetS.1 The National
Cholesterol Education Program’s Adult Treatment Panel III (ATP III) has identified
components of MetS such as abdominal obesity, atherogenic dyslipidemia, elevated blood
pressure, insulin resistance (with or without glucose intolerance), proinflammatory state, and
prothrombotic state as a multiplex risk factor for cardiovascular disease (CVD).2
Past research and treatments have aimed to reduce the risk of heart disease and diabetes by
weight loss, physical activity,3 increasing high-density lipoprotein (HDL) cholesterol4 and
lowering triglycerides (TG)5 in individuals with MetS. During the past 30 years, there has
also been a renewed interest in health benefits of omega-3 fatty acids (FA), a class of
polyunsaturated fatty acids (PUFA), that has been shown to favorably improve triglycerides
and reduce risk of CVD.6, 7 Fish and fish oils are major sources of long-chain omega-3 FA
[eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)], whereas intermediate
chain alpha-linolenic acid (ALA) is mostly provided by walnuts, soybeans, and flaxseed
oils. The American Heart Association (AHA) recommends that all adults should eat fish at
least two times a week, and for patients with documented coronary heart disease,
approximately 1g of EPA and DHA per day.8 The guidelines also suggested that two to four
grams of EPA and DHA per day might be useful in patients with hypertriglyceridemia.
There is no extensive research on the association between consumption of omega-3 fatty
acids and the prevalence of MetS. Hence, we sought to assess whether dietary omega-3 fatty
acids assessed by food questionnaires are associated with prevalent MetS in the NHLBI
Family Heart Study.
Materials and Methods
In a cross-sectional study design, we analyzed data on 4,941 subjects from the National
Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. The original cohort
consisted of 5,975 subjects; however because of missing data for omega-3, ALA, or fish
consumption, metabolic syndrome criteria or covariates, 4,941 subjects were used in
analysis. MetS was defined using the ATP III guidelines (having three or more of the
following conditions: systolic blood pressure greater than 130 mm Hg and diastolic blood
pressure greater than 85 mm Hg; triglycerides ≥ 150 mg/dL; fasting glucose ≥ 110 mg/dL;
waist circumference > 102 cm for men and 88 cm for women; and HDL cholesterol less than
40 mg/dL for men and 50 mg/dL for women2). A Willett food frequency questionnaire
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(FFQ)9 was used to obtain dietary omega-3 fatty acids as well as other nutrients using
Harvard University nutrient database supplemented by manufacturers’ information (see
previous papers for details).10 The validity of FFQ has been reported elsewhere.11, 12
Information on cigarette smoking and alcohol intake was obtained by interview during clinic
visits. Frequency of fish intake, energy intake, multivitamin intake, fruit and vegetable
consumption were obtained from the FFQ. The level of physical activity, which includes the
amount of exercise and TV watching were obtained through self-reports. CHD was assessed
from the medical history, defined as a self-reported history of myocardial infarction,
percutaneous transluminal coronary angioplasty, or coronary artery bypass graft.
Statistical Analysis
We created quintiles of dietary omega-3 FA and used the lowest group as the reference.
Since fish is a major source of long-chain omega-3 FA, we also examined whether
frequency of fish consumption (classified as 0, 1, 2, or 3 or more servings per week) was
related to MetS.
To correct for familial clustering, we used generalized estimating equations (GEE) to
calculate the prevalence odds ratios for the presence of metabolic syndrome across quintiles
of omega-3 fatty acids. GEE accounts for correlation matrix among related individuals. We
assessed confounding by age, gender (male/female), race (Caucasian/African American/
other), current drinker (yes/no), current smoker (yes/no), exercise (continuous), television
watching (quartiles based on self reported number of hours), energy intake (continuous),
fruit and vegetable intake (continuous), fiber intake (continuous), multivitamin use (yes/no),
and risk group (high risk/random/other). We obtained a p-value for linear trend by creating a
new variable that was assigned the median value of the corresponding exposure in each
quintile, and then used the new variable in the generalized estimating equations. Interaction
of omega-3 FA with gender was tested and not found to be significant.
In a secondary analysis, we repeated above analyses for fish consumption and separated
marine (EPA/DHA) from plant-based (ALA) omega-3 fatty acids. As a sensitivity analysis,
we restricted analysis to Caucasians. All p-values were two-tailed and significance level was
set at an alpha of 0.05. All analyses were performed using SAS version 9.2 (SAS Institute
Inc, Cary, NC).
Results
A full description of the NHLBI Family Heart Study has been published previously.13 The
mean age (SD) was 52.1 (13.9) years and the prevalence of MetS was 21.0%. Table 1
presents baseline characteristics according to quintiles of dietary omega-3 fatty acids.
Higher omega-3 FA was associated with older age, hypertension and history of CHD.
As shown in Table 2, dietary omega-3 FAs were not associated with prevalent MetS (p for
trend=0.97). Adjustment for age, gender, race, alcohol consumption, smoking, exercise, TV
watching, energy intake, multivitamin use, fruits, vegetable, fiber intake and risk group did
not alter results. In secondary analysis, findings were not altered when we excluded African-
Americans (n=228): from the lowest to highest quintile of dietary omega-3 FA, adjusted
odds ratios (95% CI) were 1.00 (ref), 0.91 (0.73–1.14), 1.03 (0.82–1.28), 0.95 (0.75–1.20),
and 0.97 (0.75–1.24), respectively, p for trend=0.83.
In secondary analyses, neither fish consumption nor dietary ALA was associated with
prevalent MetS (Table 3).
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Dietary Omega-3 FA & MetS
Our data did not show an association of dietary omega-3 with prevalent MetS. The effects of
omega-3 have been relatively well studied in relation to cardiovascular risk factors, results
of which have led the US Food and Drug Administration (FDA) to approve EPA/DHA use
to treat hypertriglyceridemia. This recommendation is also consistent with the AHA dietary
guidelines, recommending at least two servings of fish per week (particularly fatty
fish).14, 15 However, the association of omega-3 FA and major cardiovascular end points is
still controversial as a recent systematic review and meta-analysis revealed that omega-3
supplementation was not associated with a lower risk of all-cause mortality, cardiac death,
sudden death, myocardial infarction, or stroke.16 An important predictor of cardiovascular
disease is obesity, which is one of the major causal factors of the rapidly increasing
prevalence of MetS. Diabetes mellitus and insulin resistance are part of phenotypes used to
define MetS. In a meta-analysis, Wu et al. reported that omega-3 FA were not related to the
onset of diabetes mellitus.17 In another meta-analysis, investigators reported that increment
of each serving per week in fish consumption was associated with a slight increase in
developing type 2 diabetes mellitus in a US population.18 However, the effects of omega-3
FA on risk of MetS are not well established.
In our cross-sectional study, we did not find any association between dietary omega-3 FA
and prevalent MetS. Our findings are consistent with data from other studies. Mauno et al
reported no significant association between omega-3 PUFA and the incidence of MetS in a
longitudinal, population-based study over a 6.4-year follow up.19 In addition, one Italian
retrospective study showed no significant association of omega-3 FA with the risk of
MetS.20
Fish intake, dietary ALA, & MetS
Neither fish consumption nor ALA intake was associated with MetS in our study. Our
findings are consistent with a French study that reported no relation between higher fish
consumption and MetS.21 In contrast, a population-based prospective cohort study of
Koreans found that high consumption of fish was significantly associated with a lower risk
of MetS among men.22 Three observational studies showed that ALA intake or plasma ALA
levels were not associated with cardiovascular risk factors.
23, 24, 25 A meta-analysis of
randomized controlled trials also showed that ALA did not significantly reduce total
cholesterol, triglycerides, body mass index, LDL, or diastolic and systolic blood pressure.26
In several other studies, a significant lowering of TG was observed with increased
consumption of fish.27,28 However, in our data, higher intake of fish was related to higher
plasma TG (155.82 mg/dl) compared to no fish consumption (144.64 mg/dl). It is possible
that subjects with elevated TG were advised to consume more fish given established TG-
lowering effects of marine omega-3 FA (EPA/DHA) and our observation of paradoxical
elevated TG in the group with highest fish consumption may reflect confounding by
indication. We had no information on the cooking method for fish in this population for
further analyses. It is possible that some of the naturally occurring unsaturated fatty acids in
fish may have been altered by partial hydrogenation, and thus converted to deleterious trans-
isomers during the high-temperature heating process.29, 30
Study Limitations & Strengths
One of our study limitations is the inability to determine causal relation between dietary
omega-3 FA and MetS because of the cross-sectional study design. Information on omega-3
FA was based on a self-reported questionnaire, which might have led to an overestimation or
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underestimation of dietary omega-3 FAs. Another limitation is the use of a single FFQ,
which may not fully capture dietary habits over time. The use of a single assessment of
physical activity via self-report prevented us to control for changes in physical activity over
time in this study. Our subjects were predominantly non-Hispanic whites, which might limit
the generalizability of our findings to non-white populations. However, to date, this is the
largest multi-center, population-based study assessing the relationship between dietary
omega-3 FA, fish consumption, and ALA with prevalent MetS. The availability of
information on several covariates including physical activity, smoking, alcohol use, etc. is a
strength of this study.
Conclusion
Our findings do not support an association between dietary omega-3 FA and MetS in this
multi-center population-based study of US men and women.
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Table 2
Prevalence odds ratios (95% confidence intervals) of metabolic syndrome according to dietary omega-3 FA
Dietary omega-3 fatty
acids (Quintiles)
MetS cases / N Crude Adjusted
Model *
Q1 (0.00, 0.07) 210/970 1.00 (ref) 1.00 (ref)
Q2 (0.08, 0.14) 212/1070 0.89 (0.72–1.11) 0.90 (0.72–1.13)
Q3 (0.15, 0.21) 203/918 1.03 (0.83–1.27) 1.03 (0.82–1.28)
Q4 (0.22, 0.37) 203/1009 0.91 (0.73–1.13) 0.94 (0.74–1.18)
Q5 (0.38, 5.65) 207/974 0.98 (0.78–1.22) 0.99 (0.77–1.25)
P-value for linear trend 0.97 0.90
*
Adjusted for age, gender, race, alcohol intake (yes/no), smoking (yes/no), exercise (min/day), TV watching (hours/weekday), energy intake,
multivitamin use, fruits and vegetables intake, fiber intake, and risk group (random vs. high risk) using generalized estimating equations (GEE)
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Table 3
Prevalence odds ratios (95% confidence intervals) of metabolic syndrome according to fish consumption in
the NHLBI Family Heart Study
Number of fish
servings/ week
MetS cases / N Crude Model 1*
0 271/1341 1.00 (ref) 1.00 (ref)
1 454/2183 1.04 (0.88–1.23) 1.00 (0.84–1.18)
2 162/794 1.01 (0.82–1.26) 1.00 (0.80–1.26)
≥ 3 148/623 1.23 (0.97–1.56) 1.30 (1.00–1.68)
*
Adjusted for age, gender, race, alcohol intake (yes/no), smoking (yes/no), exercise (min/day), TV watching (hours/weekday), energy intake,
multivitamin use, fruits and vegetables intake, fiber intake, and risk group (random vs. high risk) using generalized estimating equations (GEE)
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